Cargando…
Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity?
Calcineurin inhibitors have markedly reduced acute rejection rates in renal transplantation, thus significantly improved short-term outcome. The beneficial effects are, however, tampered by acute and chronic nephrotoxicity leading to interstitial fibrosis and tubular atrophy, which impairs long-term...
Autores principales: | Mortensen, Line Aas, Bistrup, Claus, Thiesson, Helle Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705552/ https://www.ncbi.nlm.nih.gov/pubmed/29226122 http://dx.doi.org/10.3389/fmed.2017.00210 |
Ejemplares similares
-
The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial)
por: Mortensen, Line Aas, et al.
Publicado: (2018) -
Proteomic Analysis of Renal Biomarkers of Kidney Allograft Fibrosis—A Study in Renal Transplant Patients
por: Mortensen, Line Aas, et al.
Publicado: (2020) -
The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors
por: Issa, Naim, et al.
Publicado: (2012) -
Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage
por: Fels, Benedikt, et al.
Publicado: (2022) -
Mineralocorticoid Receptor Antagonism in Chronic Kidney Disease
por: Georgianos, Panagiotis I., et al.
Publicado: (2021)